photo(8).JPG

 

This is a photo of some art at the High Line urban park in New York City, which I visited just a few days before Hurricane Sandy hit. The High Line experienced damage from the hurricane, which presumably can be fixed and the park re-opened before long. The International Milk Genomics Consortium (IMGC) continues to challenge the conventional wisdom about milk. After deleting one of its articles from the October issue about the potential benefits of raw milk, it now has an intriguing article in its November issue suggesting that buttermilk could be the antidote for both many common intestinal disorders, and to susceptibility to pathogens.

 

Its article summarizing research from around the world is about the growing importance of intestinal lipids from fat and carbohydrates, called “glycolipids,” in protecting against inflammatory diseases, and even pathogens. It seems timely coming in the midst of the intense discussion following my previous two posts about the terrible price paid by families of children who become ill from raw milk, especially since it is about scientific research as apart from all the emotion that has come with the debate here.

“Unfortunately, the rapid degradation of glycolipids in the intestine, typical of inflammatory intestinal diseases, is associated with a further increase in pro-inflammatory signaling, inflammatory markers, and susceptibility to pathogens,” the article states, in making a connection between intestinal problems and pathogens. “Conditions like necrotizing enterocolitis (in infants), inflammatory bowel diseases, and Crohn’s disease (in adults) are becoming a new health problem, affecting over 1 million Americans each year. Because neither surgical nor drug interventions cure these diseases, there are increasing demands for new treatments.”

 

The answer may lie in buttermilk, the article says…likely produced from colostrum. Conventional buttermilk might offer an option as well, though more needs to be learned, the article says.

“Will drinking store bought milk provide the desired benefits?  The answer to that question is, unfortunately, no. The amount of glycolipids in store-bought milk is too low to elicit bioactive action. However, there is another possibility for recovering and concentrating these molecules from milk.


“During industrial milk processing, the fat is disrupted and, as a result, the glycolipids move from the “fat” part of the milk to the “watery” part of the milk. When butter is made, the “watery” part is a byproduct that can then be used to make buttermilk.  It is from this buttermilk that glycolipids could be extracted. It turns out that buttermilk can also be produced from colostrum – the early milk – that is naturally richer in glycolipids compared to mature milk. Colostrum contains as much as 63 mg/kg of glycolipids [5].  Therefore, buttermilk made from colostrum could be a rich source of glycolipids.”

It’s not clear whether the buttermilk would need to be produced from conventional dairy, raw milk, or from raw colostrums. Does it really matter?

I have to applaud the IMGC for remaining focused on the potential benefits to be extracted from dairy for countering chronic and pathogen disease, even if the antidote may originate with raw milk. The article concludes, “If buttermilk were to be used in clinical studies to demonstrate enhanced quality of life for people suffering from intestinal diseases, it could become the new star of the dairy industry!”